© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
November 23, 2020
November 16, 2020
November 10, 2020
Favorable phase 2 results with the TYK2 inhibitor for psoriatic arthritis at ACR 2020 coincided with announced positive phase 3 trial results for psoriasis.
October 16, 2020
October 14, 2020
A higher proportion of risankizumab users achieved improved measures for symptoms, quality of life, and mental health versus comparators.
September 18, 2020
Ustekinumab should be prescribed cautiously to those at high cardiovascular risk.
September 12, 2020
When a rheum patient might need to consult with a dermatologist.
August 20, 2020
More studies are needed on the effectiveness and safety of plaque psoriasis therapies for older patients.
July 31, 2020
The expansion makes history for the injection biologic.
June 05, 2020
The findings are based on data from a 24-week observation from an ongoing phase 3 PATERA study.